First "All-ICGNMD" paper out today in Brain!

31 July 2023

First ICGNMD 'Brain' publication showcases our remote transcontinental partnership to assess genetic architecture of NMDs across diverse populations, supporting DNA-based diagnosis, potentially enabling genetic counselling, care pathways and eligibility for gene-specific trials

Neuromuscular disease genetics in under-represented populations: increasing data diversity